Liru Xue

1.1k total citations · 1 hit paper
26 papers, 735 citations indexed

About

Liru Xue is a scholar working on Public Health, Environmental and Occupational Health, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Liru Xue has authored 26 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 8 papers in Reproductive Medicine and 7 papers in Molecular Biology. Recurrent topics in Liru Xue's work include Reproductive Biology and Fertility (14 papers), Ovarian function and disorders (4 papers) and Reproductive System and Pregnancy (4 papers). Liru Xue is often cited by papers focused on Reproductive Biology and Fertility (14 papers), Ovarian function and disorders (4 papers) and Reproductive System and Pregnancy (4 papers). Liru Xue collaborates with scholars based in China, United States and Australia. Liru Xue's co-authors include Shixuan Wang, Mingfu Wu, Qingqing Zhu, Yingying Chen, Meng Wu, Yanzhi Feng, Weicheng Tang, Jinjin Zhang, Xiaoqi Dong and Fan Xia and has published in prestigious journals such as Advanced Materials, Human Reproduction and Stem Cells.

In The Last Decade

Liru Xue

26 papers receiving 727 citations

Hit Papers

Reactive oxygen species-scavenging nanomaterials for the ... 2024 2026 2025 2024 10 20 30 40
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Reactive oxygen species-scavenging nanomaterials for the prevention and treatment of age-related diseases
    2024 48 citations Yifan Guo, Dan Chen et al. Journal of Nanobiotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liru Xue China 15 222 180 177 152 134 26 735
Wenjie Feng China 14 172 0.8× 220 1.2× 53 0.3× 102 0.7× 91 0.7× 30 646
İsmail Mert United States 19 47 0.2× 231 1.3× 65 0.4× 62 0.4× 156 1.2× 37 846
Atsushi Sugawara Japan 20 60 0.3× 297 1.6× 172 1.0× 57 0.4× 82 0.6× 98 1.2k
Youguo Chen China 16 117 0.5× 301 1.7× 34 0.2× 74 0.5× 100 0.7× 41 665
Haicheng Chen China 14 47 0.2× 264 1.5× 57 0.3× 38 0.3× 102 0.8× 29 568
Micol Massimiani Italy 12 178 0.8× 124 0.7× 111 0.6× 302 2.0× 108 0.8× 26 796
Meng Du China 19 299 1.3× 371 2.1× 61 0.3× 98 0.6× 12 0.1× 52 924
Weishuai Liu China 16 69 0.3× 245 1.4× 121 0.7× 27 0.2× 114 0.9× 41 611

Countries citing papers authored by Liru Xue

Since Specialization
Citations

This map shows the geographic impact of Liru Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liru Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liru Xue more than expected).

Fields of papers citing papers by Liru Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liru Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liru Xue. The network helps show where Liru Xue may publish in the future.

Co-authorship network of co-authors of Liru Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Liru Xue. A scholar is included among the top collaborators of Liru Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liru Xue. Liru Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wen, Jingyi, Yanzhi Feng, Liru Xue, et al.. (2024). High-fat diet-induced L-saccharopine accumulation inhibits estradiol synthesis and damages oocyte quality by disturbing mitochondrial homeostasis. Gut Microbes. 16(1). 2412381–2412381. 7 indexed citations
2.
Xue, Liru, Weicheng Tang, Jiaqiang Xiong, et al.. (2024). Ovarian microenvironment: challenges and opportunities in protecting against chemotherapy-associated ovarian damage. Human Reproduction Update. 30(5). 614–647. 30 indexed citations
3.
Tang, Weicheng, Ying Chen, Shuhong Yang, et al.. (2024). Towards prolonging ovarian reproductive life: Insights into trace elements homeostasis. Ageing Research Reviews. 97. 102311–102311. 5 indexed citations
4.
Guo, Yifan, Dan Chen, Liru Xue, et al.. (2024). Reactive oxygen species-scavenging nanomaterials for the prevention and treatment of age-related diseases. Journal of Nanobiotechnology. 22(1). 252–252. 48 indexed citations breakdown →
5.
Tang, Weicheng, Dan Chen, Jiaqiang Xiong, et al.. (2024). Multiomics insights into the female reproductive aging. Ageing Research Reviews. 95. 102245–102245. 18 indexed citations
6.
Chen, Dan, Meng Wu, Su Zhou, et al.. (2023). Semaphorin 4C regulates ovarian steroidogenesis through RHOA/ROCK1-mediated actin cytoskeleton rearrangement. Molecular Human Reproduction. 29(5). 7 indexed citations
7.
Wu, Meng, Liru Xue, Ying Chen, et al.. (2023). Inhibition of checkpoint kinase prevents human oocyte apoptosis induced by chemotherapy and allows enhanced tumour chemotherapeutic efficacy. Human Reproduction. 38(9). 1769–1783. 7 indexed citations
8.
Wu, Meng–Huang, Qingqing Zhu, Liru Xue, et al.. (2022). Adipose tissue and ovarian aging: Potential mechanism and protective strategies. Ageing Research Reviews. 80. 101683–101683. 19 indexed citations
9.
Zhu, Qingqing, et al.. (2022). Machine Learning-Assisted Ensemble Analysis for the Prediction of Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer. Frontiers in Oncology. 12. 817250–817250. 4 indexed citations
10.
Yan, Wei, Qingchun Guo, Xiangyi Li, et al.. (2022). Chronic exposure to propylparaben at the humanly relevant dose triggers ovarian aging in adult mice. Ecotoxicology and Environmental Safety. 235. 113432–113432. 23 indexed citations
11.
Wu, Tong, Dan Chen, Weicheng Tang, et al.. (2022). The effects and mechanism of taxanes on chemotherapy-associated ovarian damage: A review of current evidence. Frontiers in Endocrinology. 13. 1025018–1025018. 10 indexed citations
12.
Wu, Meng, Liru Xue, Weicheng Tang, et al.. (2022). Biomaterials and advanced technologies for the evaluation and treatment of ovarian aging. Journal of Nanobiotechnology. 20(1). 374–374. 18 indexed citations
13.
Lu, S. L., Liru Xue, Meng Yang, et al.. (2022). NIR-II fluorescence/photoacoustic imaging of ovarian cancer and peritoneal metastasis. Nano Research. 15(10). 9183–9191. 23 indexed citations
14.
Wu, Meng, Zhiyong Lu, Qingqing Zhu, et al.. (2022). DDX04+ Stem Cells in the Ovaries of Postmenopausal Women: Existence and Differentiation Potential. Stem Cells. 40(1). 88–101. 9 indexed citations
15.
Xue, Liru, Xiang Li, Jinjin Zhang, et al.. (2022). Carbon tetrachloride exposure induces ovarian damage through oxidative stress and inflammatory mediated ovarian fibrosis. Ecotoxicology and Environmental Safety. 242. 113859–113859. 9 indexed citations
16.
17.
Chen, Yingying, Liru Xue, Qingqing Zhu, Yanzhi Feng, & Mingfu Wu. (2021). Recent Advances in Second Near-Infrared Region (NIR-II) Fluorophores and Biomedical Applications. Frontiers in Chemistry. 9. 750404–750404. 69 indexed citations
18.
Wu, Meng, Lingwei Ma, Liru Xue, et al.. (2021). Co-expression of the SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in human ovaries: Identification of cell types and trends with age. Genomics. 113(6). 3449–3460. 26 indexed citations
19.
Xiong, Jiaqiang, Liru Xue, Weicheng Tang, et al.. (2021). THERAPY OF ENDOCRINE DISEASE: Novel protection and treatment strategies for chemotherapy-associated ovarian damage. European Journal of Endocrinology. 184(5). R177–R192. 19 indexed citations
20.
Wu, Meng, Lingwei Ma, Liru Xue, et al.. (2019). Resveratrol alleviates chemotherapy-induced oogonial stem cell apoptosis and ovarian aging in mice. Aging. 11(3). 1030–1044. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenjie Feng Breakdown of academic impact, for papers by İsmail Mert Breakdown of academic impact, for papers by Atsushi Sugawara Breakdown of academic impact, for papers by Youguo Chen Breakdown of academic impact, for papers by Haicheng Chen Breakdown of academic impact, for papers by Micol Massimiani Breakdown of academic impact, for papers by Meng Du Breakdown of academic impact, for papers by Weishuai Liu
Rankless by CCL
2026